Search - tctmd.com

Displaying 21 - 40 of 54

Sort: Relevancy | Date

News Industry News

Medtronic Announces Clinical Study of Transcatheter Aortic Valve Replacement in Aortic Stenosis Patients with Bicuspid Valves

September 18, 2018

No Symptoms? Some AS Patients Undergo Valve Replacement Despite Lack of Clinical Indication

Shelley Wood

September 12, 2018

News Conference News PCR London Valves 2018

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

Shelley Wood

September 11, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for July 2018

Shelley Wood

August 01, 2018

News Daily News

Concerning Rise in Younger Patients Getting TAVR, Despite Dearth of Data

L.A. McKeown

July 31, 2018

News Daily News

CMS Advisory Panel Splits on TAVR Volume Requirements

Todd Neale

July 26, 2018

News Daily News

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

Shelley Wood

July 23, 2018

News Daily News

Updated TAVR Consensus Statement Keeps Volume Requirements but Shifts Focus to Quality

Todd Neale

July 18, 2018

News Daily News

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

Caitlin E. Cox

July 10, 2018

Presentation The Structural Heart Disease Summit 2018

Frailty Assessment of TAVR and SAVR Patients: The Essential Frailty Toolset

Presenter: Howard C. Herrmann, Allan Schwartz, Jonathan Afilalo

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

Presenter: Michael J. Mack, Bernard Prendergast

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Stephan Windecker

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Presenter: Eberhard Grube, Tamim Nazif, Chetan P. Huded

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

Presenter: Eberhard Grube, Tamim Nazif, Alexandra J. Lansky

June 21, 2018

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Caitlin E. Cox

May 24, 2018

News Daily News

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

L.A. McKeown

May 11, 2018

Presentation

Causes and Associated Costs of 30-Day Readmission of TAVR vs SAVR in the US

May 11, 2018

News Daily News

Recent Stroke Heightens Risk of Perioperative Events After AVR

Todd Neale

April 25, 2018

Presentation

TAVR vs SAVR in Patients With Prior CABG

April 13, 2018

News Daily News

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Shelley Wood

April 13, 2018

Advertisement

Medtronic Announces Clinical Study of Transcatheter Aortic Valve Replacement in Aortic Stenosis Patients with Bicuspid Valves

No Symptoms? Some AS Patients Undergo Valve Replacement Despite Lack of Clinical Indication

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

TCTMD’s Top 10 Most Popular Stories for July 2018

Concerning Rise in Younger Patients Getting TAVR, Despite Dearth of Data

CMS Advisory Panel Splits on TAVR Volume Requirements

TAVR’s Two-Surgeon Sign-off Rule Must Go, Experts Say

Updated TAVR Consensus Statement Keeps Volume Requirements but Shifts Focus to Quality

Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs

Frailty Assessment of TAVR and SAVR Patients: The Essential Frailty Toolset

New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

TAVR Readmissions Similar to Surgery’s at 30 Days, but Costs Are Higher

Causes and Associated Costs of 30-Day Readmission of TAVR vs SAVR in the US

Recent Stroke Heightens Risk of Perioperative Events After AVR

TAVR vs SAVR in Patients With Prior CABG

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content